Related Experiment Video
Updated: Jul 13, 2026

Application of Biochip Microfluidic Technology to Detect Serum Allergen-specific Immunoglobulin E (sIgE)
Published on: April 21, 2019
Pay for performance for the allergist-immunologist: potential promise and problems
Michael Schatz1, Michael Blaiss, George Green
1Department of Allergy, Kaiser Permanente, San Diego, CA 92111, USA. michael.x.schatz@kp.org
Abstract:
Pay for performance is one component of a growing movement in this country to better align incentives so as to increase the quality of medical care and reduce unnecessary costs. The Physician Consortium for Quality Improvement is a national multistakeholder organization that is developing performance measures. Concerns regarding performance measures include technical concerns (eg, validity, risk adjustment, sample size, and accuracy considerations), concerns regarding the cost of implementation, and concerns regarding unintended consequences. Some data support the effectiveness of pay-for-performance programs, but more and better-designed studies are needed to rigorously assess the effectiveness of pay-for-performance programs. The Institute of Medicine 2006 report supports pay for performance "as a stimulus to foster comprehensive and system-wide improvements in the quality of healthcare." This report also recommends that implementation of pay-for-performance programs should be carefully monitored to be sure that the stated goals are being achieved and that unintended consequences are recognized as early as possible. It is important for the allergist-immunologist to be an active participant in the evolving paradigm of pay for performance, advocating for the best interests of patients and providers alike.
Related Concept Videos
Sensitivity, Specificity, and Predicted Value
Sensitivity is the...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Cross-reactivity
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Allergic Reactions
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...

